Marta Sánchez‐Soto

1.5k total citations
26 papers, 867 citations indexed

About

Marta Sánchez‐Soto is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Marta Sánchez‐Soto has authored 26 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmacology. Recurrent topics in Marta Sánchez‐Soto's work include Receptor Mechanisms and Signaling (17 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Neuropeptides and Animal Physiology (7 papers). Marta Sánchez‐Soto is often cited by papers focused on Receptor Mechanisms and Signaling (17 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Neuropeptides and Animal Physiology (7 papers). Marta Sánchez‐Soto collaborates with scholars based in United States, Spain and Germany. Marta Sánchez‐Soto's co-authors include Sergi Ferré, David R. Sibley, Hideaki Yano, Vicent Casadó, Jordi Bonaventura, Estefanía Moreno, Ning-Sheng Cai, Antoni Cortés, Enric I. Canela and Juan L. Gomez and has published in prestigious journals such as The FASEB Journal, Journal of Pharmacology and Experimental Therapeutics and Molecular Psychiatry.

In The Last Decade

Marta Sánchez‐Soto

26 papers receiving 864 citations

Peers

Countries citing papers authored by Marta Sánchez‐Soto

Since Specialization

Citations

This map shows the geographic impact of Marta Sánchez‐Soto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Sánchez‐Soto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Sánchez‐Soto more than expected).

Fields of papers citing papers by Marta Sánchez‐Soto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Sánchez‐Soto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Sánchez‐Soto. The network helps show where Marta Sánchez‐Soto may publish in the future.

Co-authorship network of co-authors of Marta Sánchez‐Soto

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Sánchez‐Soto. A scholar is included among the top collaborators of Marta Sánchez‐Soto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Sánchez‐Soto. Marta Sánchez‐Soto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GRK2 Enhances ß-arrestin Recruitment to the D2 Dopamine Receptor Through a Mechanism that is Independent From Receptor Phosphorylation or G Protein Activation 2023 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Marta Sánchez‐Soto, Julia Drube, Raphael S. Haider, R. Benjamin Free, (unknown), David R. Sibley	1
2	G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D2 Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation 2023 ·Biomolecules ·Marta Sánchez‐Soto, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Amy E. Moritz, Julia Drube, Raphael S. Haider, R. Benjamin Free, (unknown), David R. Sibley	6
3	Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search 2022 ·Molecular Psychiatry ·Jordi Bonaventura, Juan L. Gomez, (unknown), Sherry Lam, Marta Sánchez‐Soto, Patrick J. Morris, Ruin Moaddel, Hye Jin Kang, Panos Zanos, Todd D. Gould, Craig J. Thomas, David R. Sibley, Carlos A. Zarate, Michael Michaelides	27
4	Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine 2022 ·iScience ·Despoina Aslanoglou, Suzanne Bertera, Laura Friggeri, Marta Sánchez‐Soto, Jeongkyung Lee, Xiangning Xue, Ryan W. Logan, J. Robert Lane, Vijay Yechoor, Peter J. McCormick, Jens Meiler, R. Benjamin Free, David R. Sibley, Rita Bottino, Zachary Freyberg	12
5	Functional and pharmacological role of the dopamine D4 receptor and its polymorphic variants 2022 ·Frontiers in Endocrinology ·Sergi Ferré, Annabelle M. Belcher, Jordi Bonaventura, César Quiroz, Marta Sánchez‐Soto, Verònica Casadó-Anguera, Ning-Sheng Cai, Estefanía Moreno, Comfort A. Boateng, Thomas M. Keck, Benjamín Florán, Christopher J. Earley, Francisco Ciruela, Vicent Casadó, Marcelo Rubinstein, Nora D. Volkow	20
6	Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors 2021 ·Translational Psychiatry ·Despoina Aslanoglou, Suzanne Bertera, Marta Sánchez‐Soto, R. Benjamin Free, Jeongkyung Lee, Wei Zong, Xiangning Xue, Shristi Shrestha, Marcela Briššová, Ryan W. Logan, Claes B. Wollheim, Massimo Trucco, Vijay Yechoor, David R. Sibley, Rita Bottino, Zachary Freyberg	68
7	Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability 2021 ·Molecular Psychiatry ·Jordi Bonaventura, Sherry Lam, (unknown), Matthew A. Boehm, Juan L. Gomez, Óscar Solís, Marta Sánchez‐Soto, Patrick J. Morris, Ida Fredriksson, Craig J. Thomas, David R. Sibley, Yavin Shaham, Carlos A. Zarate, Michael Michaelides	178
8	Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse models 2021 ·Genome Medicine ·Eduardo Pauls, Sergi Bayod, Lídia Mateo, Víctor Alcalde, (unknown), Marta Sánchez‐Soto, Takaomi C. Saido, Takashi Saito, Antonio Berenguer, Camille Stephan‐Otto Attolini, Marina Gay, Eliandre de Oliveira, Miquel Duran‐Frigola, Patrick Aloy	15
9	Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D2 Dopamine Receptor 2021 ·Molecular Pharmacology ·R. Benjamin Free, (unknown), (unknown), Yoon Namkung, Varun V. Prabhu, (unknown), (unknown), Marta Sánchez‐Soto, J. Robert Lane, Stéphane A. Laporte, Lei Shi, Joshua E. Allen, David R. Sibley	22
10	Heteromerization between α2A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disorders 2021 ·Pharmacological Research ·Verònica Casadó-Anguera, Estefanía Moreno, Marta Sánchez‐Soto, Ning Cai, Jordi Bonaventura, (unknown), Marcelo Rubinstein, Antoni Cortés, Enric I. Canela, Sergi Ferré, Vicent Casadó	7
11	A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity 2020 ·Science Signaling ·Marta Sánchez‐Soto, Ravi Kumar Verma, (unknown), (unknown), Annah M. Moore, Amy E. Moritz, Comfort A. Boateng, Hideaki Yano, R. Benjamin Free, Lei Shi, David R. Sibley	30
12	Control of glutamate release by complexes of adenosine and cannabinoid receptors 2020 ·BMC Biology ·Attila Köfalvi, Estefanía Moreno, Arnau Cordomí, Ning-Sheng Cai, Víctor Fernández‐Dueñas, Samira G. Ferreira, Ramón Guixà-González, Marta Sánchez‐Soto, Hideaki Yano, Verònica Casadó-Anguera, Rodrigo A. Cunha, Ana M. Sebastião, Francisco Ciruela, Leonardo Pardo, Vicent Casadó, Sergi Ferré	62
13	Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens 2019 ·Molecular Neurobiology ·Xavier Guitart, Estefanía Moreno, William Rea, Marta Sánchez‐Soto, Ning-Sheng Cai, César Quiroz, Vivek Kumar, (unknown), Antoni Cortés, Enric I. Canela, Christopher Bishop, Amy Hauck Newman, Vicent Casadó, Sergi Ferré	33
14	Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding Sites 2018 ·Molecular Pharmacology ·(unknown), Jennie Conroy, R. Benjamin Free, Noel Southall, Marc Ferrer, Marta Sánchez‐Soto, Amy E. Moritz, (unknown), (unknown), Prashi Jain, Steve Titus, Lisa A. Hazelwood, Jeffrey Aubé, J. Robert Lane, Kevin J. Frankowski, David R. Sibley	29
15	α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands 2018 ·Molecular Neurobiology ·Marta Sánchez‐Soto, Verònica Casadó-Anguera, Hideaki Yano, Brian J. Bender, Ning-Sheng Cai, Estefanía Moreno, Enric I. Canela, Antoni Cortés, Jens Meiler, Vicent Casadó, Sergi Ferré	24
16	Revisiting the Functional Role of Dopamine D4 Receptor Gene Polymorphisms: Heteromerization-Dependent Gain of Function of the D4.7 Receptor Variant 2018 ·Molecular Neurobiology ·Marta Sánchez‐Soto, Hideaki Yano, Ning-Sheng Cai, Verònica Casadó-Anguera, Estefanía Moreno, Vicent Casadó, Sergi Ferré	15
17	A Novel Class of Dopamine D₄ Receptor Ligands Bearing an Imidazoline Nucleus 2016 ·ChemMedChem ·(unknown), Alessandro Bonifazi, Diego Dal Ben, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Maria Pigini, Wilma Quaglia, Ajiroghene Thomas, Amy Hauck Newman, Sergi Ferré, Marta Sánchez‐Soto, Thomas M. Keck, Fabio Del Bello	6
18	Functional Selectivity of Allosteric Interactions within G Protein–Coupled Receptor Oligomers: The Dopamine D1-D3 Receptor Heterotetramer 2014 ·Molecular Pharmacology ·Xavier Guitart, Gemma Navarro, Estefanía Moreno, Hideaki Yano, Ning-Sheng Cai, Marta Sánchez‐Soto, Sandeep Kumar Barodia, (unknown), Josefa Mallol, Antoni Cortés, Carme Lluı́s, Enric I. Canela, Vicent Casadó, Peter J. McCormick, Sergi Ferré	102
19	l-DOPA disrupts adenosine A2A–cannabinoid CB1–dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies 2014 ·Experimental Neurology ·Annalisa Pinna, Jordi Bonaventura, (unknown), Marta Sánchez‐Soto, Nicola Simola, Josefa Mallol, Carme Lluı́s, Giulia Costa, Younis Baqi, Christa E. Müller, Antoni Cortés, Peter J. McCormick, Enric I. Canela, Eva Martínez‐Pinilla, José L. Lanciego, Vicent Casadó, Marie‐Thérèse Armentero, Rafael Franco	68
20	l-DOPA-treatment in primates disrupts the expression of A2A adenosine–CB1 cannabinoid–D2 dopamine receptor heteromers in the caudate nucleus 2013 ·Neuropharmacology ·Jordi Bonaventura, Alberto J. Rico, Estefanía Moreno, Salvador Sierra, Marta Sánchez‐Soto, Natasha Luquin, (unknown), Christa E. Müller, Eva Martínez‐Pinilla, Antoni Cortés, Josefa Mallol, Marie‐Thérèse Armentero, Annalisa Pinna, Enric I. Canela, Carme Lluı́s, Peter J. McCormick, José L. Lanciego, Vicent Casadó, Rafael Franco	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact